Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.

Bjornsson HT, Brown LJ, Fallin MD, Rongione MA, Bibikova M, Wickham E, Fan JB, Feinberg AP.

J Natl Cancer Inst. 2007 Aug 15;99(16):1270-3. Epub 2007 Aug 8.

PMID:
17686827
2.

Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.

Ravenel JD, Broman KW, Perlman EJ, Niemitz EL, Jayawardena TM, Bell DW, Haber DA, Uejima H, Feinberg AP.

J Natl Cancer Inst. 2001 Nov 21;93(22):1698-703.

PMID:
11717330
3.

Epigenetic differences between Wilms' tumours in white and east-Asian children.

Fukuzawa R, Breslow NE, Morison IM, Dwyer P, Kusafuka T, Kobayashi Y, Becroft DM, Beckwith JB, Perlman EJ, Reeve AE.

Lancet. 2004 Feb 7;363(9407):446-51.

PMID:
14962525
4.

Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.

Cui H, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, Lobanenkov VV, Feinberg AP.

Cancer Res. 2001 Jul 1;61(13):4947-50.

5.

Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.

Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, Grundy R, Ferguson-Smith AC, Maher ER.

Br J Cancer. 2005 Apr 25;92(8):1574-80.

6.

Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.

Mummert SK, Lobanenkov VA, Feinberg AP.

Genes Chromosomes Cancer. 2005 Jun;43(2):155-61.

PMID:
15761865
7.

Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.

Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP.

Nat Genet. 1994 Jul;7(3):433-9. Erratum in: Nat Genet 1994 Oct;8(2):203.

PMID:
7920665
8.

Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.

Sullivan MJ, Taniguchi T, Jhee A, Kerr N, Reeve AE.

Oncogene. 1999 Dec 9;18(52):7527-34.

9.

Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.

Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE.

Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2159-63.

10.
11.
12.

Global demethylation in loss of imprinting subtype of Wilms tumor.

Ludgate JL, Le Mée G, Fukuzawa R, Rodger EJ, Weeks RJ, Reeve AE, Morison IM.

Genes Chromosomes Cancer. 2013 Feb;52(2):174-84. doi: 10.1002/gcc.22017. Epub 2012 Oct 17.

PMID:
23074036
13.

Altered expression of imprinted genes in Wilms tumors.

Hubertus J, Lacher M, Rottenkolber M, Müller-Höcker J, Berger M, Stehr M, von Schweinitz D, Kappler R.

Oncol Rep. 2011 Mar;25(3):817-23. doi: 10.3892/or.2010.1113. Epub 2010 Dec 20.

PMID:
21174059
14.
15.

Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.

Brown KW, Power F, Moore B, Charles AK, Malik KT.

Mol Cancer Res. 2008 Jul;6(7):1114-23. doi: 10.1158/1541-7786.MCR-08-0002.

16.

Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.

Honda S, Arai Y, Haruta M, Sasaki F, Ohira M, Yamaoka H, Horie H, Nakagawara A, Hiyama E, Todo S, Kaneko Y.

Br J Cancer. 2008 Dec 2;99(11):1891-9. doi: 10.1038/sj.bjc.6604754. Epub 2008 Oct 28.

17.

Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.

Bhusari S, Yang B, Kueck J, Huang W, Jarrard DF.

Prostate. 2011 Nov;71(15):1621-30. doi: 10.1002/pros.21379. Epub 2011 Mar 22.

18.

Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.

Fukuzawa R, Anaka MR, Heathcott RW, McNoe LA, Morison IM, Perlman EJ, Reeve AE.

J Pathol. 2008 Aug;215(4):377-87. doi: 10.1002/path.2366.

PMID:
18484682
19.

Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.

Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, Nichols TD, Marks JR, Berchuck A.

Mol Cancer Res. 2006 Apr;4(4):283-92.

20.

Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.

Ulaner GA, Vu TH, Li T, Hu JF, Yao XM, Yang Y, Gorlick R, Meyers P, Healey J, Ladanyi M, Hoffman AR.

Hum Mol Genet. 2003 Mar 1;12(5):535-49.

PMID:
12588801

Supplemental Content

Support Center